Microscopic artificial swimmers
By R. Dreyfus, J. Baudry, Marcus L. Roper, M. Fermigier, Howard A. Stone, J. Bibette. Nature, 2005
1,684 citations recorded by the source corpus.
Subfields: Atomic and Molecular Physics, and Optics, Biomedical Engineering, Condensed Matter Physics
View Paper: https://www.semanticscholar.org/paper/8d5bdff8ebb8e82e9e7f053a22662e1f7cd16062
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Atomic and Molecular Physics, and Optics
- Eric Lauga
- T. Powers
- J. Elgeti
- Arezoo Motavalizadeh Ardekani
- Gaojin Li
- Gerhard Gompper
- Roland G. Winkler
- S. Krishnamurthy
In Biomedical Engineering
- Eric Lauga
- S. Michelin
- Bradley J. Nelson
- Jake J. Abbott
- Metin Sitti
- Gerhard Gompper
- Roland G. Winkler
- Gaojin Li
In Condensed Matter Physics
- Eric Lauga
- S. Michelin
- Bradley J. Nelson
- Roland G. Winkler
- Jake J. Abbott
- Gerhard Gompper
- Andreas Menzel
- Metin Sitti
Citations in the corpus
- Biomedical Applications of Untethered Mobile Milli/Microrobots (2015, background): “(i) biohybrid magnetic microswimmer [24].”
- Microswimming in viscoelastic fluids (2021, background): “In the lab, different types of artificial swimmers have been designed and fabricated to mimic the swimming behavior of microorganisms; this includes self-phoretic colloids [29], particles externally actuated by magnetic, acoustic, electric fields [30, 31, 32], vibrated granular matter [33] and”
- The shape – morphing performance of magnetoactive soft materials (2021, background): “Moreover, MSMs demonstrate other interesting capabilities, for example, locomotion [16,90,91], highly programable [92,93], and precise shape transformation [94,95] and even remote heat generation [96,97].”
- Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions (2016, neutral): “Although microscopic artificial swimmers 23 could be envisioned as an alternative to the use of natural microorganisms, embedding an equivalent level of functionality in artificial agents to compete against such natural microorganisms in delivering therapeutics effectively to tumour hypoxic regions…”